Xylem (XYL) Cost of Revenue (2010 - 2026)

Xylem's Cost of Revenue history runs 17 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• On a quarterly basis, Cost of Revenue rose 1.61% year-over-year to $1.3 billion in Q1 2026; TTM through Mar 2026 was $5.6 billion, a 3.93% increase from a year earlier, with the FY2025 full-year figure at $5.6 billion, up 3.93% from the prior year.
• Cost of Revenue eased to $1.3 billion in Q1 2026 per XYL's latest filing, from $1.5 billion in the prior quarter.
• Across five years, Cost of Revenue topped out at $1.5 billion in Q4 2025 and bottomed at $805.0 million in Q1 2022.
• The 5-year median for Cost of Revenue is $1.3 billion (2023), against an average of $1.2 billion.
• Across the five-year window, Cost of Revenue jumped 53.27% in 2023 and advanced 0.61% in 2024, its largest moves.
• Year by year, Cost of Revenue stood at $933.0 million in 2022, then surged by 45.98% to $1.4 billion in 2023, then gained by 2.72% to $1.4 billion in 2024, then gained by 4.72% to $1.5 billion in 2025, then retreated by 9.76% to $1.3 billion in 2026.
• Per Business Quant, the three latest XYL Cost of Revenue figures stand at $1.3 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.4 billion (Q3 2025).